288 related articles for article (PubMed ID: 8430709)
1. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma.
Hande KR; Garrow GC
Am J Med; 1993 Feb; 94(2):133-9. PubMed ID: 8430709
[TBL] [Abstract][Full Text] [Related]
2. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.
Saccente SL; Kohaut EC; Berkow RL
Pediatr Nephrol; 1995 Oct; 9(5):569-73. PubMed ID: 8580012
[TBL] [Abstract][Full Text] [Related]
3. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
Kedar A; Grow W; Neiberger RE
Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
[TBL] [Abstract][Full Text] [Related]
4. Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphoma.
Boccia RV; Longo DL; Lieber ML; Jaffe ES; Fisher RI
Cancer; 1985 Nov; 56(9):2295-7. PubMed ID: 3840408
[TBL] [Abstract][Full Text] [Related]
5. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials.
Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A
Klin Padiatr; 1998; 210(4):279-84. PubMed ID: 9743966
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
[TBL] [Abstract][Full Text] [Related]
7. Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature review.
Chiang J; Chan A; Lian T; Tay K; Quek R; Tao M; Lim ST
Asia Pac J Clin Oncol; 2011 Dec; 7(4):351-6. PubMed ID: 22151984
[TBL] [Abstract][Full Text] [Related]
8. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma.
Cohen LF; Balow JE; Magrath IT; Poplack DG; Ziegler JL
Am J Med; 1980 Apr; 68(4):486-91. PubMed ID: 7369230
[TBL] [Abstract][Full Text] [Related]
9. [Tumor lysis syndrome after treatment for mediastinal non-Hodgkin's lymphoma].
Kaneki T; Hachiya T; Hayano T; Koizumi T; Kubo K; Harada T; Kawashima A; Sekiguchi M; Honda T; Maruyama Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):414-9. PubMed ID: 9212666
[TBL] [Abstract][Full Text] [Related]
10. Asystole during combination chemotherapy for non-Hodgkin's lymphoma: the acute tumor lysis syndrome.
Van Der Klooster JM; Van Der Wiel HE; Van Saase JL; Grootendorst AF
Neth J Med; 2000 Apr; 56(4):147-52. PubMed ID: 10727760
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma.
Stapleton FB; Strother DR; Roy S; Wyatt RJ; McKay CP; Murphy SB
Pediatrics; 1988 Dec; 82(6):863-9. PubMed ID: 3186376
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma.
Karagiannis A; Tsorlalis I; Kakafika A; Pateinakis P; Perifanis V; Harsoulis F
Ann Hematol; 2005 May; 84(5):343-6. PubMed ID: 15580501
[TBL] [Abstract][Full Text] [Related]
13. Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.
Suzuki T; Takeuchi M; Saeki H; Yamazaki S; Koga H; Abe D; Nishimura M; Nakaseko C; Nakasa H; Nakamura H; Ariyoshi N; Kitada M
Clin Ther; 2010 Mar; 32(3):527-31. PubMed ID: 20399989
[TBL] [Abstract][Full Text] [Related]
14. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Yang H; Rosove MH; Figlin RA
Am J Hematol; 1999 Dec; 62(4):247-50. PubMed ID: 10589082
[TBL] [Abstract][Full Text] [Related]
15. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome.
Dunlay RW; Camp MA; Allon M; Fanti P; Malluche HH; Llach F
Ann Intern Med; 1989 Jan; 110(2):162-4. PubMed ID: 2909207
[No Abstract] [Full Text] [Related]
17. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
18. [Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Xia Y; Sun XF; Zhang CQ; Zhen ZJ; Wang ZH; Wang ZQ
Ai Zheng; 2004 Nov; 23(11 Suppl):1448-50. PubMed ID: 15566654
[TBL] [Abstract][Full Text] [Related]
19. Tumor lysis syndrome: risk factors, diagnosis, and management.
Burns RA; Topoz I; Reynolds SL
Pediatr Emerg Care; 2014 Aug; 30(8):571-6; quiz 577-9. PubMed ID: 25098804
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-induced tumor lysis syndrome in high-grade non-Hodgkin's lymphoma.
Malik IA; Abubakar S; Alam F; Khan A
South Med J; 1994 Mar; 87(3):409-11. PubMed ID: 8134869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
